This work was an investigator-initiated study and partly funded by Guerbet, France. Guerbet is the manufacturer of Lipiodol® Ultra Fluid. The funders had no role in the study design, data collection, the analyses performed or the interpretation of the study data. Conflicts of interestsI.R. reports receiving travel fee for presenting at the ASRM 2019 from Guerbet. K.R. has nothing to disclose. N.W. has nothing to disclose. V.M. reports receiving travel-and speakers fee as well as research grants from Guerbet. K.D. reports receiving travel-and speakers fee from Guerbet. M.B. has nothing to disclose. B.W.M. is supported by a NHMRC Practioner Fellowship (GNT1082548). B.W.M. reports consultancy for ObsEva, Merck KGaA and Guerbet and travel and research grants from Merck KGaA and Guerbet. C.K. has nothing to disclose. Guerbet is the manufacturer of Lipiodol® Ultra Fluid.

The impact of the COVID-19 pandemic on infertility and endometriosis patients in the Netherlands: The use of virtual care, quality of life and patient-centeredness,

Her research project focuses on diagnostic and therapeutic consequences of evaluation of the Fallopian tubes.